Life Sciences Research for Lifelong Health

Emma Minihane

Emma grew up on the island of Jersey and went on to study Molecular & Cellular Biology at the University of Bath. Her interest in signalling sparked from a research project she undertook with Dr Jim Caunt, studying ERK1/2 and PKB responses to nerve growth factor in the PC12 model system.
After a 5-month stint travelling in the USA (visiting 23/50 States), Emma re-entered the world of science and joined the Cook lab in 2016. Her work is in collaboration with AstraZeneca, focusing on combining BH3 mimetics with kinase inhibitors in cancer.
Still an islander at heart, Emma enjoys many water sports and misses being by the sea. She is a jazz drummer (yes really!) and is also currently teaching herself how to play the guitar (very badly). 

Note from Editor.
It is unclear from Emma’s account if she is very bad at teaching herself or very bad at playing the guitar. No doubt such ambiguity in writing will be sorted by the time she comes to write her thesis.

Latest Publications

An mTORC1-to-CDK1 Switch Maintains Autophagy Suppression during Mitosis.

Odle RI, Walker SA, Oxley D

Molecular cell
1097-4164: (2019)

PMID: 31733992

Targeting melanoma's MCL1 bias unleashes the apoptotic potential of BRAF and ERK1/2 pathway inhibitors.

Sale MJ, Minihane E, Monks NR

Nature communications
10 2041-1723:5167 (2019)

PMID: 31727888

Identification of a novel orally bioavailable ERK5 inhibitor with selectivity over p38α and BRD4.

Myers SM, Miller DC, Molyneux L

European journal of medicinal chemistry
178 1768-3254:530-543 (2019)

PMID: 31212132